Sanofi to buy 12 percent of Alnylam, expands rare-disease drug deal
An employee walks into an office of French drugmaker Sanofi in Shanghai August 2, 2013.
Credit: Reuters/Aly Song
Read the original here:
feeds.reuters
Healthy Living News From around The Web
Sanofi to buy 12 percent of Alnylam, expands rare-disease drug deal – Reuters